Classification of Alzheimer's disease stages by analyzing prefrontal near-infrared signals during olfactory stimulation with machine learning...International Society for Gerontechnology 13th World Conference, October 22-26, 2022, Daegu, South Korea

Purpose Alzheimer's disease (AD) is known as a disease caused by the accumulation of beta-amyloid or tau protein in neurons, blocking signal transmission and causing death. Since there is no cure for this disease, early detection is an important aspect of AD (Rasmussen J et al., 2019). It has been r...

Descripción completa

Detalles Bibliográficos
Publicado en:Gerontechnology Vol. 21; pp. 3 - 4
Autores principales: Kim, J. G., Kim, J. W.
Formato: abstract proceedings research Journal Article
Publicado: International Society for Gerontechnology Oct2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=161396104&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 161396104
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15691101
        904R
      jtl: Gerontechnology
      issn: 15691101
      maglogo: N
    pubinfo:
      dt: Oct2022
      vid: 21
      pid: 54298
      pub: International Society for Gerontechnology
    artinfo:
      ui:
        161396104
        161396104
        161396104
        10.4017/gt.2022.21.s.821.3.sp3
        161396104
      ppf: 3
      ppct: 1
      formats:
      tig:
        atl: Classification of Alzheimer's disease stages by analyzing prefrontal near-infrared signals during olfactory stimulation with machine learning...International Society for Gerontechnology 13th World Conference, October 22-26, 2022, Daegu, South Korea
      aug:
        au:
          Kim, J. G.
          Kim, J. W.
        affil: Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Republic of Korea
      sug:
        subj:
          Alzheimer's Disease
          Machine Learning
          Health Screening
          Sensory Stimulation
          Spectroscopy, Near-Infrared
          Congresses and Conferences South Korea
          South Korea
      ab: Purpose Alzheimer's disease (AD) is known as a disease caused by the accumulation of beta-amyloid or tau protein in neurons, blocking signal transmission and causing death. Since there is no cure for this disease, early detection is an important aspect of AD (Rasmussen J et al., 2019). It has been reported that the olfactory function decreases earlier than the cognitive dysfunction in AD patients. (Roberts RO et al., 2015). We have previously reported that the brain hemodynamic signals measured by functional near-infrared spectroscopy during olfactory stimulation could classify the stage of Alzheimer's disease based on a statistical model using 98 patients (55 normal, 26 mild cognitive impairments, 16 dementia) (Kim J et al., 2022). In this study, we recruited additional 34 subjects and applied machine learning to find its potential in AD screening. Method The existing data from 97 participants were used for internal verification, and 34 new participants' data were used as external verification data. All patients were recruited from the GARD cohort. We applied a statistical method and machine learning algorithm to both datasets. For a statistical model, a linear regression was employed, and a naive Bayes-based machine learning algorithm was chosen as a machine learning algorithm applied for AD screening. Results and Discussion A naive Bayes-based machine learning performed better than the statistical method on both internal and external validation datasets. The statistical model reported a classification accuracy of 87% in patients with mild cognitive impairment and Alzheimer's dementia on 97 internal validations and 63% on 34 external validations. On the other hand, naive Bayes-based machine learning algorithm achieved 95% accuracy on internal validation data and 85% accuracy on external validation data suggesting that machine learning has the potential to screen AD from various patient groups better than a statistical model.
      pubtype: Academic Journal
      doctype:
        abstract
        proceedings
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N